Senior insider sale
HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$645.8K
8.83K shares
What this filing means
CONNAUGHTON BERNADETTE plans to sell 8.83K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $645.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2025ACC: 0001950047-25-006654
Director
Since Sep 2018
8.83K
Shares to sell
$645.8K
Approx. market value
8.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/30/2021
8.83KTotal acquired8.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/30/2021 | Restricted Stock Units N/A | 8.83K | — |
| Total | 8.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.83K
Market value
$645.8K
9/2/2025
Total
Units
8.83K
Value
$645.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/2/2025 | 8.83K | $645.8K | NASDAQ | Planned |
| Total | 8.83K | $645.8K | ||